topic 13 - drug design and discovery Flashcards

1
Q

what is a drug?

A

“a chemical substance used to prevent or cure disease”

or

“a substance which has a physiological effect when introduced into the body”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

drug discovery pipeline

A

source of compounds
pool of potential drug molecules
hit compounds
lead compounds
clinical candidate
preclinical development
manufacturing
clinical trials
marketing, use and monitoring.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is fumaria officinalis - drug fumitory?

A

Fumaria officinalis – “drug fumitory”

Used medicinally across Europe to treat eyes, as a digestive aid, a diuretic, for skin blemishes, and more…

Contains fumaric acid – named after the plant

Fumaric acid was later found to be active against psoriasis

Dimethyl fumarate (an analogue) is more effective, and an approved drug against psoriasis and multiple sclerosis

Its mechanism is still not clear.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is Artemisia annua - sweet wormwood?

A

Used medicinally in China against malaria symptoms

Recommended by Li Shizhen in 16th Century pharmacopoeia

Chinese scientists screened a list of 2000 traditional medicines in the 70s

Tu Youyou discovered the compound artemisinin

Best extraction method is similar to traditional preparation

Game-changing antimalarial.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is centella asiatca (gotu kola) and madecassic acid (MA)?

A

Centella Asiatica (Gotu Kola)
Popular medicinal herb in SE Asia
Used for: High blood pressure, arthritis, wound healing, anti-ageing

Madecassic acid (MA): Natural product from C. Asiatica
Antiproliferative activity against liver cancer
Chemical derivatives improved potential
Liver cancer issue in Vietnam – 25,000 death per year

Project Aim: Bring MA derivatives forward as potential new therapeutics against liver cancer, which could be produced within Vietnam

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the benefits of natural products?

A

All natural products have some kind of biological activity already

Could be produced by agricultural or biotechnological methods

Provides access to unusual/diverse structures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the drawbacks of natural products?

A

Can be difficult to obtain in high yields

Total synthesis challenging

Compounds are not optimised

Could be allergens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is phenotypic drug discovery / phenotypic screening?

A

Phenotypic screening: approaches looking only at the final effect of a drug, rather than relying on knowledge/hypotheses of how the drug works

This has historically been the way in which drugs were discovered, and it is still useful

Screening of natural products has given us paclitaxel, a key cancer treatment, isolated from the bark of the pacific yew tree.

Phenotypic screening can also work for large libraries of synthetic compounds (i.e. not natural products).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is target based drug discovery?

A

Most modern industrial drug discovery is target-based

This means that a certain biomolecule has been identified as problematic, and a drug will be developed to change its behaviour, with the aim of certain final effect.

Requires knowledge of biochemistry in question

A good target should be efficacious, safe, and “druggable” = readily influenced by small molecules.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

target based drug discovery pt 2

A

Targets must be selected well to maximise activity and minimise side-effects

Biology usually has more than one way to send the same message

One protein may interact with many others, some beneficial, some harmful.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the benefits of designed synthetic compounds?

A

Synthesis straightforward (comparatively)

Readily modified at any point to tune properties

Mechanism of action usually well understood.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the drawbacks of designed synthetic compounds?

A

Limited to molecules which are easily made

Chirality and larger 3D structures rarer

Does not work so well on proteins without small molecule binding pockets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is screening and selection?

A

Unbiased approaches take a huge random library (small drug-like molecules, fragments of drug-like molecules, peptides, oligonucleotides, other oligomers).

Screening: measure each molecule’s interaction with the target.

Selection: use some affinity measurement to separate binders from non-binders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the benefits of screening and selection?

A

Test millions of molecules at once

Could uncover unexpected activities

Exploit molecular biology techniques – phage display of peptides, PCR, sequencing, etc.

Target any protein with larger molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the drawbacks of screening and selection?

A

Might not find any good hits – even a library of >1 million compounds could be poorly designed

Limited to libraries which can easily be made

Larger molecules may have trouble getting through membranes etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is hit-to lead and lead optomisation?

A

Hit-to-lead: compounds from the library are short-listed according to

Synthetic accessibility

Specificity

Toxicity

Physical properties

Lead optimisation: the compounds will be optimised for

Physicochemical properties (polarity, HBs, molecular weight)

ADME

Toxicity

All of these will involve generation of structure-activity relationships (SAR) which correlate small changes in structure with changes in biological activity

A good compound will have SAR which can be rationalised using knowledge of the target.

A compound which shows little SAR is likely not specific for the target

17
Q

what are clinical trials, and the phases?

A

Drugs work by interfering with biological processes – no drug is completely safe.

The dose makes the poison.

Phase I: Testing safety in a small group of healthy volunteers (10 – 100). Safe dosages will be established, and how the body processes the drug (pharmacokinetics) will be monitored. Unblinded = patients and doctors know what the drug is.

Phase II: Small scale test for for efficacy. 50 – 500 patients with the disease will be enrolled. Safety and pharmacokinetics will be monitored. Placebos are used as a comparison. Either single-blind (patient unaware if they are in the test or placebo group) or double-blind (both unaware).

Phase III: Large scale test for efficacy, with 500 – 3000 or more patients with the disease over many sites. Stringent comparison to existing treatment. Randomised controlled double-blind trials.

If Phase III is successful, the company will apply for approval.

Phase IV: Follow-up studies are conducted post-approval to monitor response in the wider population.